Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

In silico SNP analysis of the breast cancer antigen NY-BR-1

  • Zeynep Kosaloglu1, 5,
  • Julia Bitzer2, 5,
  • Niels Halama2, 5,
  • Zhiqin Huang3, 6,
  • Marc Zapatka3, 6,
  • Andreas Schneeweiss4, 5,
  • Dirk Jäger1, 2, 5 and
  • Inka Zörnig2, 5Email author
Contributed equally
BMC Cancer201616:901

https://doi.org/10.1186/s12885-016-2924-7

Received: 3 August 2016

Accepted: 3 November 2016

Published: 18 November 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
3 Aug 2016 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
3 Nov 2016 Editorially accepted
18 Nov 2016 Article published 10.1186/s12885-016-2924-7

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Clinical Cooperation Unit “Applied Tumor Immunity”, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ)
(2)
Department of Medical Oncology, National Center for Tumor Diseases (NCT) and University Hospital Heidelberg
(3)
Division of Molecular Genetics, German Cancer Research Center (DKFZ)
(4)
Department of Obstetrics and Gynecology, National Center for Tumor Diseases (NCT) and University Hospital Heidelberg
(5)
(6)

Advertisement